The healthtech scene in Europe is having a strong year in 2025, with major momentum behind digital health, AI diagnostics, and personalized care. Even though there’s been a slight slowdown in deal volume, investor interest hasn’t faded, digital health alone pulled in €3.02 billion in 2024, up 19% from the year before.
Here’s a breakdown of the VCs that are driving innovation and backing the future of healthcare across Europe.
What’s Trending in Health VC Right Now
- Early-stage is still the sweet spot—72% of digital health deals in 2024 were early-stage.
- AI, data-first healthcare, and digital infrastructure are getting a lot of attention.
- Investors are focusing more on companies with scalable, clinically validated products that can go global.
VCs to Know in European Healthtech
Also worth watching:
APEX Ventures (Vienna), Vinci S.A. (Warsaw), Seedcamp, Forbion, Kurma Partners, Sofinnova, Index Ventures, and Entrepreneur First, all with active healthtech portfolios in Europe.
Why These VCs Matter
What makes these investors stand out isn’t just the capital, they bring deep sector knowledge, regional understanding, and actual support. Whether it’s helping startups navigate tough regulations, refine their GTM strategy, or build clinical partnerships, these VCs go beyond the check.
Some go wide across Europe, while others double down on specific regions (like DACH or CEE), offering real local insight.
Looking Ahead
Even with global pressure on pharma R&D and cautious investment vibes in some sectors, European healthtech is still thriving. The demand for smarter, tech-driven care isn’t slowing down, and VCs are playing a major role in scaling the solutions that will define the next decade of healthcare.
These are the funds to watch, and the ones shaping what comes next.
Article and cover image by Pauline Olazabal.
